FDA vaccines committee will complete recommendations for influenza vaccine formulation for the 2000-2001 flu season on March 10. An update on the status of rotavirus vaccines and a briefing on the vaccine safety action plan are also scheduled. The meeting starts at 8 a.m. both days at the Holiday Inn in Silver Spring, Md
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth